Philadelphia Campus | CHOP Research Institute
 

Philadelphia Campus

We are looking for adolescents who have a current diagnosis of anorexia nervosa or other specified feeding and eating disorder and one parent to participate in a study to help us understand higher order thinking differences in teens with eating disorders.

The first few years of life are a time of rapid growth and brain development.

The goal of this study is to determine why Eosinophilic Esophagitis (EoE) occurs and attempt to develop new blood tests for this condition.

The goal of this study is to evaluate the effectiveness of a new blood test for Eosinophilic Esophagitis (EoE).

The primary purpose of the CAHptain study is to explore the safety and efficacy of tildacerfont in children and adolescents aged 2 to 17 years of age with classic CAH, and evaluate if it may improve hormonal balance and allow children to take lower doses of glucocorticoids.

Our team has partnered with Moderna on a clinical trial for patients with glycogen storage disease type 1a (GSD1a).

HIV infection can cause harm to the brain and negatively affect memory, learning, and decision making in daily activities.

CReWS (the Collaborative Registry for Williams Syndrome) has been developed for, and is owned by the Williams Syndrome Association.

This study involves an investigational cellular therapy called Afamitresgene Autoleucel.

The purpose of this study is to find out more about mRNA-3705, a study drug that is being tested and is not approved by the U.